"The Prices of Prescription Drugs: Exclusivity, Market Dynamics, and Public Policy"
Access & Features
- Open to the public
John Osborn is a Senior Advisor with Hogan Lovells in Washington DC, an Affiliate Professor of the University of Washington Law School, and a regular contributor on Health Policy to Forbes.com and STAT. Mr. Osborn has been a senior executive with life sciences and healthcare companies, including a Merck joint venture, McKesson Specialty Health/US Oncology, Cephalon, Dendreon and Onyx Pharmaceuticals and has served in all three branches of the Federal government, and as a member of the presidential advisory commission on public diplomacy. Mr. Osborn currently serves as a member of the W&M Public Policy Board of Advisors.